Abstract

In this study, some new thiosemicarbazide and their corresponding 1,3,4-thiadiazole derivatives containing pyridine nuclei were synthesized. Their structures were established based on FT-IR, 1HNMR , 13CNMR , 2D-NMR (HSQC) spectral data and elemental analysis. The MCF-7 and NIH3T3 cells were used to test the compound's anticancer effects. Among the compounds; 4a, 4b, 4d and 4g showed the most potent cytotoxic activity against MCF-7 at IC50 of 3.102±0.096 μM, 8.737±0.103 μM, 11.190±0.088 μM and 12.630±0.101 μM, respectively.Their inhibitory activity was assessed against the in vitro aromatase enzyme. Compounds 4a, 4b, 4d and 4g exhibited the promising aromatase inhibition activity with IC50 value of 0.027±0.002 µM, 0.068±0.005 µM, 1.456±0.009 µM and 3.316±0.001 µM, respectively (the standard drug letrazole has an IC50 value of 0.023±0.002 μM). The molecular docking studies were used to identify the key molecular interactions between the compounds 4a, 4b, 4d and 4g and the aromatase enzyme. Additionally, the physicochemical, druglikeness and pharmacokinetic properties of compounds were also evaluated.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call